Finch Therapeutics Group Inc - ESG Rating & Company Profile powered by AI
Other corporations in the rating industry group for Finch Therapeutics Group Inc are displayedin the table. The Sustainability score for Finch Therapeutics Group Inc indicates the company's transparency towards the United Nations Sustainable Development Goals. Jump to the bottom of the webpage for potential risks for Finch Therapeutics Group Inc based on sector, location and size.
Finch Therapeutics Group Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.9; made up of an environmental score of 2.0, social score of 3.2 and governance score of 6.4.
3.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
1004 | Xeris Pharmaceuticals Inc | 4.0 | High |
1004 | Xenon Pharmaceuticals Inc | 4.0 | High |
... | ... | ... | |
1089 | Finch Therapeutics Group Inc | 3.9 | Medium |
1089 | Aclaris Therapeutics Inc | 3.9 | Medium |
1089 | Allogene Therapeutics Inc | 3.9 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Finch Therapeutics Group Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Finch Therapeutics Group Inc report the average age of the workforce?
Sign up for free to unlockDoes Finch Therapeutics Group Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Finch Therapeutics Group Inc offer flexible work?
Sign up for free to unlockDoes Finch Therapeutics Group Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Finch Therapeutics Group Inc conduct supply chain audits?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Finch Therapeutics Group Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose water use targets?
Sign up for free to unlockDoes Finch Therapeutics Group Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Finch Therapeutics Group Inc have a product recall in the last two years?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Finch Therapeutics Group Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Finch Therapeutics Group Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose parental leave metrics?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Finch Therapeutics Group Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Finch Therapeutics Group Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Finch Therapeutics Group Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose its waste policy?
Sign up for free to unlockDoes Finch Therapeutics Group Inc report according to TCFD requirements?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose energy use targets?
Sign up for free to unlockDoes Finch Therapeutics Group Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Finch Therapeutics Group Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Finch Therapeutics Group Inc
These potential risks are based on the size, segment and geographies of the company.
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides difficile infection, as well as for the treatment of chronic hepatitis B virus. It is also developing FIN-211, an orally administered enriched consortia product candidate for use in the treatment of autism spectrum disorder; and TAK-524 and FIN-525, which are orally administered targeted consortia product candidates for the treatment of ulcerative colitis and Crohn's disease. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; Skysong Innovations LLC; and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts.